BENATI, DANIELA
 Distribuzione geografica
Continente #
NA - Nord America 3.033
EU - Europa 1.574
AS - Asia 301
OC - Oceania 22
SA - Sud America 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.937
Nazione #
US - Stati Uniti d'America 3.014
IT - Italia 483
GB - Regno Unito 435
SE - Svezia 196
DE - Germania 136
CN - Cina 122
HK - Hong Kong 116
UA - Ucraina 83
FR - Francia 80
BG - Bulgaria 33
FI - Finlandia 32
NL - Olanda 27
TR - Turchia 23
AU - Australia 22
IE - Irlanda 19
BE - Belgio 17
CA - Canada 15
CH - Svizzera 12
IN - India 8
KR - Corea 8
VN - Vietnam 8
RU - Federazione Russa 6
IR - Iran 5
SG - Singapore 5
ES - Italia 3
GR - Grecia 3
AT - Austria 2
BZ - Belize 2
CO - Colombia 2
DK - Danimarca 2
JP - Giappone 2
MX - Messico 2
MY - Malesia 2
UY - Uruguay 2
CL - Cile 1
CZ - Repubblica Ceca 1
EU - Europa 1
HR - Croazia 1
LV - Lettonia 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 4.937
Città #
Fairfield 473
Southend 362
Chandler 261
Ashburn 245
Woodbridge 217
Houston 195
Seattle 166
Nyköping 164
Wilmington 164
Cambridge 156
Dearborn 148
Jacksonville 143
Hong Kong 114
Ann Arbor 89
Modena 53
San Diego 50
Bologna 44
Princeton 40
Beijing 35
Sofia 33
Eugene 31
Helsinki 29
New York 28
Falls Church 19
Milan 17
Bremen 16
Brussels 16
Izmir 15
London 14
Redwood City 14
Dublin 13
Paris 13
Shanghai 13
Boardman 12
Rome 12
Parma 11
Phoenix 9
Des Moines 8
Dong Ket 8
Hefei 8
Los Angeles 8
Napoli 8
San Jose 8
Trento 8
Canberra 7
Munich 7
Wuhan 7
Adelaide 6
Amstelveen 6
Nanjing 6
Reggio Emilia 6
Toronto 6
Dallas 5
Minerbio 5
Roncoferraro 5
Vignola 5
Avigliano Umbro 4
Empoli 4
Fresno 4
Gunzenhausen 4
Kunming 4
Palermo 4
Piacenza 4
Soave 4
Sydney 4
Trapani 4
Villejuif 4
Acton 3
Ankara 3
Bari 3
Buffalo 3
Campagna Lupia 3
Casagiove 3
Castelfranco Emilia 3
Duderstadt 3
Fuzhou 3
Jongno-gu 3
Limbiate 3
Madrid 3
Montréal 3
Naples 3
New Delhi 3
Nottingham 3
Porretta Terme 3
Prescot 3
Saint Petersburg 3
San Francisco 3
Siena 3
Vicenza 3
Zhengzhou 3
Zola Predosa 3
Absecon 2
Albuquerque 2
Alexandria 2
Amsterdam 2
Belize City 2
Bergamo 2
Binasco 2
Campegine 2
Chelmsford 2
Totale 3.695
Nome #
In vivo editing of the human mutant Rhodopsin gene by electroporation of plasmid-based CRISPR/Cas9 in the mouse retina 280
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 254
CRISPR/Cas9 gene editing in vitro and in retinal cells in vivo 247
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 246
Altered Responses to Homeostatic Cytokines in Patients with Idiopathic CD4 Lymphocytopenia 169
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 163
An efficient in vitro transposition method by a transcriptionally regulated sleeping beauty system packaged into an integration defective lentiviral vector 156
MHC Class II Tetramer Labeling of Human Primary CD4+ T Cells from HIV Infected Patients 151
DNA vaccination by electroporation amplifies broadly cross-restricted public TCR clonotypes shared with HIV Controllers 149
A High Frequency of HIV-Specific Circulating Follicular Helper T Cells Is Associated with Preserved Memory B Cell Responses in HIV Controllers 148
Public T cell receptors confer high-avidity CD4 responses to HIV controllers 147
HIV controllers maintain a population of highly efficient Th1 effector cells in contrast to patients treated in the long term 145
CD4+ T cell-mediated HLA class II cross-restriction in HIV controllers 144
The shc family protein adaptor, Rai, negatively regulates T cell antigen receptor signaling by inhibiting ZAP-70 recruitment and activation 143
The strepsipteran endoparasite Xenos vesparum alters the immunocompetence of its host, the paper wasp Polistes dominulus 138
Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases 133
In vitro and in vivo CRISPR/Cas9-mediated genome editing to downregulate dominant mutations in Rhodopsin gene 126
Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus 125
Simvastatin impairs humoral and cell-mediated immunity in mice by inhibiting lymphocyte homing, T-cell activation and antigen cross-presentation 122
Gene editing prospects for treating inherited retinal diseases 118
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 113
SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of β-catenin and its nuclear signaling 104
SRC family kinases as potential therapeutic targets for malignancies and immunological disorders 102
Bcr-Abl stabilizes β-catenin in chronic myeloid leukemia through its tyrosine phosphorylation 99
CRISPR-mediated T cell engineering against Non-Small Cell Lung Cancer 99
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 97
Characterization of high avidity CD4+ T cells in HIV Controllers 94
Specific cTfh frequency correlates with memory B cell responses in HIV controllers. 92
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients 89
Comparison of the antigen sensitivity of Gag-specific CD4+ T cell responses in controlled HIV infection and HIV vaccination 86
HIV Controller CD4+ T cells preferentially express a public TCR clonotype that confers high avidity responses against Gag 79
Frequent sharing of high-affinity TCRs in naturally controlled HIV infection: implications for vaccination 78
T cell receptors from the HIV-specific repertoire, means for their production and therapeutic uses thereof 77
Molecular characterization of high avidity CD4+ T cells in HIV Controllers 72
Public TCRs confer high-avidity CD4 responses to HIV controllers 67
CRISPR-Mediated Genome Editing to Redirect T Cells against Non-Small Cell Lung Cancer 56
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 53
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 52
In vitro and in vivo genome editing of the RHO gene to downregulate dominant mutations 47
Erratum: Simvastatin inhibits the MHC class II pathway of antigen presentation by impairing Ras superfamily GTPases (European Journal of Immunology (2006) vol. 36 (11) 10.1002/eji.200636567)) 44
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 35
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 21
Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders 21
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 20
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 18
CRISPR-mediated genome editing to redirect T cells against Non-Small Cell Lung Cancer 17
Totale 5.036
Categoria #
all - tutte 20.056
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.056


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019202 0 0 0 0 0 0 0 0 0 0 95 107
2019/20201.116 100 31 17 58 139 205 178 139 102 42 76 29
2020/2021847 114 23 78 64 74 62 54 110 43 104 83 38
2021/2022797 54 91 61 23 42 47 55 40 85 59 148 92
2022/20231.005 108 102 98 87 123 115 29 69 125 19 64 66
2023/2024513 32 53 55 64 94 30 48 85 20 32 0 0
Totale 5.036